|
1
|
Olnes MJ and Erlich R: A review and update
on cholangiocarcinoma. Oncology. 66:167–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brito AF, Abrantes AM, Encarnaçâo JC,
Tralhâo JG and Botelho MF: Cholangiocarcinoma: From molecular
biology to treatment. Med Oncol. 32:2452015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeOliveira ML, Cunningham SC, Cameron JL,
Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ and Schulick
RD: Cholangiocarcinoma: Thirty-one-year experience with 564
patients at a single institution. Ann Surg. 245:755–762. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakeeb A, Pitt HA, Sohn TA, Coleman J,
Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ and Cameron
JL: Cholangiocarcinoma: A spectrum of intrahepatic, perihilar, and
distal tumors. Ann Surg. 224:463–475. 1996. View Article : Google Scholar
|
|
5
|
Shaib Y and El-Serag HB: The epidemiology
of cholangiocarcinoma. Semin Liver Dis. 24:115–125. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He XR and Wu XP: Difference in biological
characteristics and sensitivity to chemotherapy and radiotherapy
between intrahepatic and extrahepatic cholangiocarcinoma cells in
vitro. Chin Med Sci J. 23:54–59. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carriaga MT and Henson DE: Liver,
gallbladder, extrahepatic bile ducts, and pancreas. Cancer. 75(1
Suppl): S171–S190. 1995. View Article : Google Scholar
|
|
8
|
Aljiffry M, Walsh MJ and Molinari M:
Advances in diagnosis, treatment and palliation of
cholangiocarcinoma: 1990-2009. World J Gastroenterol. 15:4240–4262.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nathan H, Aloia TA, Vauthey JN, Abdalla
EK, Zhu AX, Schulick RD, Choti MA and Pawlik TM: A proposed staging
system for intrahepatic cholangiocarcinoma. Ann Surg Oncol.
16:14–22. 2009. View Article : Google Scholar
|
|
10
|
Liu B, Hervé J, Bioulac-Sage P, Valogne Y,
Roux J, Yilmaz F, Boisgard R, Guettier C, Calès P, Tavitian B, et
al: Sodium iodide symporter is expressed at the preneoplastic
stages of liver carcinogenesis and in human cholangiocarcinoma.
Gastroenterology. 132:1495–1503. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim JH, Han SY, Lee SW, Baek YH, Kim HY,
Kim JH, Jeong JS, Roh YH, Kim YH, Park BH, et al: Sodium iodide
symporter and phosphatase and tensin homolog deleted on chromosome
ten expression in cholangiocarcinoma analysis with
clinicopathological parameters. Gut Liver. 6:374–380. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guerrieri F, Piconese S, Lacoste C,
Schinzari V, Testoni B, Valogne Y, Gerbal-Chaloin S, Samuel D,
Bréchot C, Faivre J and Levrero M: The sodium/iodide symporter NIS
is a transcriptional target of the p53-family members in liver
cancer cells. Cell Death Dis. 4:e8072013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Riesco-Eizaguirre G and Santisteban P: A
perspective view of sodium iodide symporter research and its
clinical implications. Eur J Endocrinol. 155:495–512. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kogai T and Brent GA: The sodium iodide
symporter (NIS): Regulation and approaches to targeting for cancer
therapeutics. Pharmacol Ther. 135:355–370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dohán O, De la Vieja A, Paroder V, Riedel
C, Artani M, Reed M, Ginter CS and Carrasco N: The sodium/iodide
symporter (NIS): Characterization, regulation, and medical
significance. Endocr Rev. 24:48–77. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lacroix L, Mian C, Caillou B, Talbot M,
Filetti S, Schlumberger M and Bidart JM: Na(+)/I(-) symporter and
Pendred syndrome gene and protein expressions in human
extra-thyroidal tissues. Eur J Endocrinol. 144:297–302. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Spitzweg C, Dutton CM, Castro MR, Bergert
ER, Goellner JR, Heufelder AE and Morris JC: Expression of the
sodium iodide symporter in human kidney. Kidney Int. 59:1013–1023.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wapnir IL, van de Rijn M, Nowels K, Amenta
PS, Walton K, Montgomery K, Greco RS, Dohan O and Carrasco N:
Immunohistochemical profile of the sodium/iodide symporter in
thyroid, breast, and other carcinomas using high density tissue
microarrays and conventional sections. J Clin Endocrinol Metab.
88:1880–1888. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Altorjay A, Dohan O, Szilagyi A, Paroder
M, Wapnir IL and Carrasco N: Expression of the Na+/I- symporter
(NIS) is markedly decreased or absent in gastric cancer and
intestinal metaplastic mucosa of Barrett esophagus. BMC Cancer.
7:52007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gaertner FC, Rohde F, Mueller J, Blechert
B, Janssen KP and Essler M: Endogenous expression of the sodium
iodide symporter mediates uptake of iodide in murine models of
colorectal carcinoma. Int J Cancer. 125:2783–2791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Parthasarathy KL and Crawford ES:
Treatment of thyroid carcinoma: Emphasis on high-dose 131 I
outpatient therapy. J Nucl Med Technol. 30:165–175. 2002.
|
|
22
|
Mansi L, Moncayo R, Cuccurullo V,
Dottorini ME and Rambaldi PF: Nuclear medicine in diagnosis,
staging and follow-up of thyroid cancer. Q J Nucl Med Mol Imaging.
48:82–95. 2004.PubMed/NCBI
|
|
23
|
Grubman S, Perrone RD, Lee DW, Murray SL,
Rogers LC, Wolkoff LI, Mulberg AE, Cherington V and Jefferson DM:
Regulation of intracellular pH by immortalized human intrahepatic
biliary epithelial cell lines. Am J Physiol. 266:G1060–G1070.
1994.PubMed/NCBI
|
|
24
|
Hohenester S, Maillette de Buy Wenniger L,
Jefferson DM, Oude Elferink RP and Beuers U: Biliary bicarbonate
secretion constitutes a protective mechanism against bile
acid-induced injury in man. Dig Dis. 29:62–65. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gomes AR, Abrantes AM, Brito AF, Laranjo
M, Casalta-Lopes JE, Gonçalves AC, Sarmento-Ribeiro AB, Botelho MF
and Tralhäo JG: Influence of P53 on the radiotherapy response of
hepatocellular carcinoma. Clin Mol Hepatol. 21:257–267. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Abrantes AM, Serra ME, Gonçalves AC, Rio
J, Oliveiros B, Laranjo M, Rocha-Gonsalves AM, Sarmento-Ribeiro AB
and Botelho MF: Hypoxia-induced redox alterations and their
correlation with 99mTc-MIBI and 99mTc-HL-91 uptake in colon cancer
cells. Nucl Med Biol. 37:125–132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brito AF, Abrantes AM, Ribeiro M, Oliveira
R, Casalta-Lopes J, Gonçalves AC, Sarmento-Ribeiro AB, Tralhäo JG
and Botelho MF: Fluorine-18 fluorodeoxyglucose uptake in
hepatocellular carcinoma: Correlation with glucose transporters and
p53 expression. J Clin Exp Hepatol. 5:183–189. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Levenberg K: A method for the solution of
certain non-linear problems in least squares. Quartly of Applied
Mathematics. 2:164–168. 1944. View Article : Google Scholar
|
|
29
|
Marquardt DW: An algorithm for
least-squares estimation of non-linear parameters. J Soc Industrial
Appl Mathematics. 11:431–441. 1963. View Article : Google Scholar
|
|
30
|
Kuchar M, Oliveira MC, Gano L, Santos I
and Kniess T: Radioiodinated sunitinib as a potential radiotracer
for imaging angiogenesis-radiosynthesis and first
radiopharmacological evaluation of 5-[125I]Iodo-sunitinib. Bioorg
Med Chem Lett. 22:2850–2855. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mendes F, Sales T, Domingues C, Schugk S,
Abrantes AM, Gonçalves AC, Teixo R, Silva R, Casalta-Lopes J, Rocha
C, et al: Effects of X-radiation on lung cancer cells: The
interplay between oxidative stress and P53 levels. Med Oncol.
32:2662015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative CT method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar
|
|
33
|
Ribeiro IP, Rodrigues JM, Mascarenhas A,
Kosyakova N, Caramelo F, Liehr T, Melo JB and Carreira IM:
Cytogenetic, genomic, and epigenetic characterization of the HSC-3
tongue cell line with lymph node metastasis. J Oral Sci. 60:70–81.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ribeiro IP, Caramelo F, Esteves L, Menoita
J, Marques F, Barroso L, Miguéis J, Melo JB and Carreira IM:
Genomic predictive model for recurrence and metastasis development
in head and neck squamous cell carcinoma patients. Sci Rep.
7:138972017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ribeiro IP, Caramelo F, Marques F,
Domingues A, Mesquita M, Barroso L, Prazeres H, Juliäo MJ, Baptista
IP, Ferreira A, et al: WT1, MSH6, GATA5 and PAX5 as epigenetic oral
squamous cell carcinoma biomarkers-a short report. Cell Oncol
(Dordr). 39:575–582. 2016.
|
|
36
|
Malhi H and Gores GJ: Review article: The
modern diagnosis and therapy of cholangiocarcinoma. Aliment
Pharmacol Ther. 23:1287–1296. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Micali S, Bulotta S, Puppin C, Territo A,
Navarra M, Bianchi G, Damante G, Filetti S and Russo D: Sodium
iodide symporter (NIS) in extrathyroidal malignancies: Focus on
breast and urological cancer. BMC Cancer. 14:3302014. View Article : Google Scholar
|
|
38
|
Chen L, Altmann A, Mier W, Eskerski H,
Leotta K, Guo L, Zhu R and Haberkorn U: Radioiodine therapy of
hepatoma using targeted transfer of the human sodium/iodide
symporter gene. J Nucl Med. 47:854–862. 2006.PubMed/NCBI
|
|
39
|
Verburg FA, Brans B and Mottaghy FM:
Molecular nuclear therapies for thyroid carcinoma. Methods.
55:230–237. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Marques IA, Neves AR, Abrantes AM, Pires
AS, Tavares-da-Silva E, Figueiredo A and Botelho MF: Targeted alpha
therapy using Radium-223: From physics to biological effects.
Cancer Treat Rev. 68:47–54. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Haber AH and Rothstein BE:
Radiosensitivity and rate of cell division: 'Law of bergonié and
tribondeau'. Science. 163:1338–1339. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu L, Li D, Chen Z, Yang J, Ma Y, Cai H,
Shan C, Lv Z and Zhang X: Wild-Type P53 induces sodium/iodide
symporter expression allowing radioiodide therapy in anaplastic
thyroid cancer. Cell Physiol Biochem. 43:905–914. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Moon DH, Lee SJ, Park KY, Park KK, Ahn SH,
Pai MS, Chang H, Lee HK and Ahn IM: Correlation between
99mTc-pertechnetate uptakes and expressions of human sodium iodide
symporter gene in breast tumor tissues. Nucl Med Biol. 28:829–834.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cianfarani F, Baldini E, Cavalli A,
Marchioni E, Lembo L, Teson M, Persechino S, Zambruno G, Ulisse S,
Odorisio T and D'Armiento M: TSH receptor and thyroid-specific gene
expression in human skin. J Invest Dermatol. 130:93–101. 2010.
View Article : Google Scholar
|
|
45
|
Damle AA, Narkar AA and Badwe RA:
Radioiodide uptake and sodium iodide symporter expression in breast
carcinoma. Indian J Exp Biol. 49:416–422. 2011.PubMed/NCBI
|
|
46
|
Lacoste C, Hervé J, Bou Nader M, Dos
Santos A, Moniaux N, Valogne Y, Montjean R, Dorseuil O, Samuel D,
Cassio D, et al: Iodide transporter NIS regulates cancer cell
motility and invasiveness by interacting with the rho guanine
nucleotide exchange factor LARG. Cancer Res. 72:5505–5515. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Alotaibi H, Tuzlakoglu-Oztürk M and
Tazebay UH: The thyroid Na+/I− symporter: Molecular
characterization and genomic regulation. Mol Imaging Radionucl
Ther. 26(Suppl 1): S92–S101. 2017. View Article : Google Scholar
|
|
48
|
Lindenthal S, Lecat-Guillet N, Ondo-Mendez
A, Ambroise Y, Rousseau B and Pourcher T: Characterization of
small-molecule inhibitors of the sodium iodide symporter. J
Endocrinol. 200:357–365. 2009. View Article : Google Scholar
|
|
49
|
Khan KH, Yap TA, Yan L and Cunningham D:
Targeting the PI3K-AKT-mTOR signaling network in cancer. Chin J
Cancer. 32:253–265. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liau JY, Tsai JH, Yuan RH, Chang CN, Lee
HJ and Jeng YM: Morphological subclassification of intrahepatic
cholangiocarcinoma: Etiological, clinicopathological and molecular
features. Mod Pathol. 27:1163–1173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kumar M, Zhao X and Wang XW: Molecular
carcinogenesis of hepatocellular carcinoma and intrahepatic
cholangiocarcinoma: One step closer to personalized medicine? Cell
Biosci. 1:52011. View Article : Google Scholar : PubMed/NCBI
|
